维普中文期刊产品整合服务
13篇 您的检索式:作者名="Regan Williams"
    题名 作者 年代 出处 被引量
1Cardiovascular drugs in the treatment of infantile hemangioma显示文摘Since the introduction of propranolol in the treatment of complicated infantile hemangiomas(IH) in 2008, other different beta-blockers, including timolol, acetabutolol, nadolol and atenolol, have been successfully used for the same purpose. Various hypotheses including vasoconstriction, inhibition of angiogenesis and the induction of apoptosis in proliferating endothelial cells have been advanced as the potential beta-blockerinduced effect on the accelerated IH involution, although the exact mechanism of action of beta-blockers remains unknown. This has generated an extraordinary interest in IH research and has led to the discovery of the role of the renin-angiotensin system(RAS) in the biology of IH, providing a plausible explanation for the beta-blocker induced effect on IH involution and the development of new potential indications for RAS drugs such as angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the treatment of IH. This review is focused on the current use of cardiovascular drugs in the treatment of IH.Israel Fernandez-Pineda Regan Williams Lucia Ortega-Laureano Ryan Jones 2016World Journal of Cardiology2016,8,1:4
2IGF-I treatment of insulin resistance显示文摘McDonald A Williams RM Regan FM 2007Eur J Endocrinol2007,1571,:1
3Improving gastroschisis outcomes: Does birth place matter?显示文摘Kate B. Savoie Eunice Y. Huang Shahroz K. Aziz Martin L. Blakely Sid Dassinger Amanda R. Dorale Eileen M. Duggan Matthew T. Harting Troy A. Markel Stacey D. Moore-Olufemi Sohail R. Shah Shawn D. St. Peter Koujen Tsao Deidre L. Wyrick Regan F. Williams 2014Journal of Pediatric Surgery2014,,:1
4Arthroscopic Debridement of the Elbow for Arthrofibrosis Resulting From Nondisplaced Fracture of the Radial Head显示文摘Peter C. Lapner Jordan M. Leith William D. Regan 2005Arthroscopy: The Journal of Arthroscopic and Related Surgery2005,,12:1
5Treatment with recombinant human insulin-like growth factor (rhIGF)-Ⅰ/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance显示文摘Regan FM Williams RM McDonald A Umpleby AM Acerini CL O'Rahilly S 2010J Clin Endocrinol Metab2010,95,5:1
6MBM fuel feeding system design and evaluation for FBG pilot plant显示文摘William A. Campbell Terry Fonstad Todd Pugsley Regan Gerspacher 2012Waste Management2012,,6:1
7ECFMG assessment of clinical competence of graduates of foreign medical schools显示文摘 Stillman PL Norcini JJ Friedman M Regan MB Williams RG Kachur EK Haggerty MA Wilson MP 1993JAMA1993,270,9:1
8IGF-I treatment of insulin resistance显示文摘McDonald A Williams R M Regan F M 2007Eur J Endocrinol2007,157,1:1
9Treatment with lrecombinant human insulin-like growth factor (rhlGF)-I/rhlGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance 显示文摘Regan FM Williams RM McDonald A 2010J Clin Endoerinol Metab2010,95,5:1
10Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance 显示文摘Regan FM Williams RM McDonald A 2010J Clin Endocrinol Metab2010,95,5:1
11Treatment With recombinant human insulin-like growthfactor ( rhIGF )/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance显示文摘Regan FM Williams RM McDonald A 2010J Clin Endocrinol Metab2010,95,5:1
12Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study显示文摘William R. Brugge Kent Lewandrowski Elizabeth Lee-Lewandrowski Barbara A. Centeno Tara Szydlo Susan Regan Carlos Fernandez del Castillo Andrew L. Warshaw 2004Gastroenterology2004,,5:1
13有助于OLED产业化的可溶解工艺显示文摘可溶解工艺是一种有可能提高OLED显示的商业化现状的工艺技术。在这篇文章中,DuPont公司就其最近在可溶解工艺技术上的开发进展进行了探讨。William Feehery David Flattery Norman Herron Charlie Lang Marie O'Regan 王刚 2008现代显示2008,,5:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费